[RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].
D032761:Animal Experimentation; D000818:Animals; D001774:Blood Chemical Analysis; D004285:Dogs; D005441:Fluids and Secretions; D007004:Hypoglycemic Agents; D007408:Intestinal Absorption; D008660:Metabolism; D011743:Pyrimidines; D011817:Rabbits; D011868:Radioisotopes; D011877:Radionuclide Imaging; D051381:Rats; D012106:Research; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D013460:Sulfur Isotopes; D014556:Urine
D007004:Hypoglycemic Agents; D011743:Pyrimidines; D011868:Radioisotopes; D013424:Sulfanilamides; D013449:Sulfonamides; D013460:Sulfur Isotopes; D000077145:Sulfanilamide; C030986:pyrimidine
ANTIDIABETICS; BLOOD CHEMICAL ANALYSIS; DOGS; EXCRETION; EXPERIMENTAL LAB STUDY; INTESTINAL ABSORPTION; METABOLISM; PYRIMIDINES; RABBITS; RADIOISOTOPE SCANNING; RATS; SULFONAMIDES; SULFUR ISOTOPES; URINE
RESORPTION, VERTEILUNG UND AUSSCHEIDUNG VON RADIOAKTIV MARKIERTEM 2-BENZOLSULFONAMIDO-5(BETA-METHOXY-AETHOXY)-PYRIMIDIN (GLYCODIAZIN) IM TIERVERSUCH.